An academic research network and a contract researcher, both based in Germany, have adopted the MARVIN EDC Software from XClinical.
The GPOH research center, which focuses on pediatric oncology and hematology, will begin using the software in one registry and three clinical trials being conducted to investigate cancers in children. Later, the center hopes to use the solution for records of children suffering from malignant diseases and blood diseases. GPOH needs included a validated system, as well as vendor experience in combining complex registries with clinical trials in established databases, according to an XClinical announcement.
Contract researcher HCTC had similar criteria, the announcement says. Participation in CDISC was another factor. HCTC will be using MARVIN in two large therapy optimization trials for the treatment of hepatitis.
- here's the announcement